Key Metrics
CiteScore 

6.3
H-Index 

67
Impact Factor 

< 5
SJR 

Q1Pharmacology

SNIP 

0.8
Recommended pre-submission checks
Powered by 

Topics Covered on Current Vascular Pharmacology
Current Vascular Pharmacology Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
| Overview | |
| Publisher | BENTHAM SCIENCE PUBL LTD |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2003 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Current Vascular Pharmacology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Current Vascular Pharmacology
Metalloproteinases 2 and 9 as Biomarkers in Acute Elevation of Blood Pressure.
- 9 May 2026
- Current vascular pharmacology
The Use of Colchicine in Cardiovascular Disease: Anti-Inflammatory Mechanisms and Clinical Utility.
- 8 May 2026
- Current vascular pharmacology
Is the Cardiovascular Risk Increased in Patients with Isolated Systolic Hypertension and Anemia?
- 8 May 2026
- Current vascular pharmacology
Periodontal Disease and Cardiovascular Risk Factors.
- 7 May 2026
- Current vascular pharmacology
Chitosan-Saponin-Bentonite Nanocomposites Prevent Doxorubicin-Induced Cardiovascular Toxicity by Inhibiting Oxidative Stress and Apoptosis.
- 4 May 2026
- Current vascular pharmacology
Peripheral Arterial Disease Outcome in Patients with ESRD on Hemodialysis: A Study from a Developing Country.
- 30 Apr 2026
- Current vascular pharmacology
Metalloproteinases 2 and 9 as Biomarkers in Acute Elevation of Blood Pressure.
- 9 May 2026
- Current vascular pharmacology
The Use of Colchicine in Cardiovascular Disease: Anti-Inflammatory Mechanisms and Clinical Utility.
- 8 May 2026
- Current vascular pharmacology
Is the Cardiovascular Risk Increased in Patients with Isolated Systolic Hypertension and Anemia?
- 8 May 2026
- Current vascular pharmacology
Periodontal Disease and Cardiovascular Risk Factors.
- 7 May 2026
- Current vascular pharmacology
Chitosan-Saponin-Bentonite Nanocomposites Prevent Doxorubicin-Induced Cardiovascular Toxicity by Inhibiting Oxidative Stress and Apoptosis.
- 4 May 2026
- Current vascular pharmacology
Peripheral Arterial Disease Outcome in Patients with ESRD on Hemodialysis: A Study from a Developing Country.
- 30 Apr 2026
- Current vascular pharmacology